Dr Reddy’s gains on launch of Vigabatrin powder

The company launched Vigabatrin powder in 500 mg per packet, a therapeutic equivalent generic version of Sabril (vigabatrin) powder, approved by the US Food and Drug Administration (USFDA).




Dr. Reddy’s Laboratories' stock gained more than a percent intraday on August 20 after the company launched Vigabatrin powder (oral solution).


The company launched Vigabatrin powder in 500 mg per packet, a therapeutic equivalent generic version of Sabril (vigabatrin) powder, approved by the US Food and Drug Administration (USFDA).

At 11:01 hours, the stock was quoting Rs 2,539.60, up to Rs 29.10, or 1.16 percent on the BSE.


Best Share Market News, Click Here To Get More News - Share Market tips, for 2 Days Free Trial give a missed call @9644405057 and Get Share Market Services.

Comments

Popular posts from this blog

Daily equity Market By Ripplesadvisory Report 16-Aug-2016

11-year data suggests bears control D-Street in September; can bulls defy odds?

Oil prices mixed; Brent eases as trade tensions weigh